CSPC is a leading pharma company in China, with integrated capabilities of R&D, manufacturing, and c
Location: China, Hebei, Shijiazhuang City
Employees: 10001+
Investors 1
| Date | Name | Website |
| - | Hony Capit... | honycapita... |
Mentions in press and media 2
| Date | Title | Description |
| 24.08.2021 | Alphamab Oncology and CSPC Achieved an Licensing Cooperation on Anti-HER2 Bispecific Antibody KN026 in Mainland China | SUZHOU, China, Aug. 24, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced today that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Jiangsu Alphamab" or "the Company"), a wholly-owned subsidiary of ... |
| - | CSPC Pharmaceutical Secures USD2.1 Billion Global Licensing Deal with Madrigal for Oral GLP-1 Drug | (Yicai) July 31 -- CSPC Pharmaceutical Group has granted Madrigal Pharmaceuticals exclusive global rights to a preclinical oral small molecule glucagon-like peptide-1 weight-loss drug and orforglipron derivative. The deal could be worth ove... |